CorTricuspid ECM Valve
Phase 3- Indications
- Tricuspid valve disease, Endocarditis, Congenital heart valve disease
Company intelligence / Profile preview
CorMatrix Cardiovascular
Roswell, Georgia, United Statescormatrix.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
CorMatrix Cardiovascular develops regenerative medical devices using its proprietary extracellular matrix (ECM) technology. The company has received multiple FDA clearances for products such as the Cor Patch epicardial patch and Tyke cardiac tissue repair device. Its tricuspid ECM heart valve program has advanced into an early feasibility IDE study with expanded enrollment approved by the FDA. Over its history, more than ~160,000 devices have been implanted worldwide. In June 2017, it sold several first-to-market product lines to Aziyo Biologics but continues to develop a robust pipeline focused on unmet needs in congestive heart failure and valvular disease.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceBiologic (Extracellular matrix-based biomaterial)Regenerative medicine device
- Industry
- Implantable Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Asset/product line sale partnership with Aziyo Biologicsacademic collaborations with Georgia Tech/Purdue University researchers
Beyond the preview
Go deeper on CorMatrix Cardiovascular.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CorMatrix Cardiovascular.